Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Detailed Quotes

PHAR Pharming Group

Watchlist
13.845
+0.162+1.18%
Close  01/26 16:00 ET
High
13.845
Open
13.845
Turnover
4.91K
Low
13.845
Pre Close
13.683
Volume
354.00
Market Cap
903.24M
P/E(TTM)
30.77
52wk High
15.000
Shares
65.24M
P/E(Static)
60.19
52wk Low
6.100
Float Cap
872.70M
Bid/Ask %
0.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
0.10
Historical Low
6.100
Dividend TTM
--
Div Yield TTM
--
P/B
4.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
13.858
Lot Size
1
Float Cap
872.70M
Bid/Ask %
0.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
0.10
Historical Low
6.100
Dividend TTM
--
P/B
4.51
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
13.858
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
CEO: Dr. Sijmen (Simon) de Vries, M.D.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist